


Pharmaceuticals & Biotechnology | Small Cap
Mono Pharmacare Ltd demonstrates a mixed financial performance. The company shows remarkable growth in revenue, operating profit, EPS, assets and net income. Profitability is generally strong, supported by good gross profit margins, ROCE, ROE, operating margin and net margin. The company's solvency position appears reasonable, indicating a balanced approach to debt and equity. However, liquidity is a concern, as reflected in lower cash and operating cash flow ratios. Efficiency metrics are weak, particularly in inventory and receivables management. The company's coverage ratios are also somewhat low, suggesting a limited ability to cover interest and dividend payments. Overall, Mono Pharmacare exhibits strong growth and profitability but needs to address its liquidity and efficiency challenges to ensure sustainable financial health.
Mono Pharmacare Ltd demonstrates a mixed financial performance. The company shows remarkable growth in revenue, operating profit, EPS, assets and net income. Profitability is generally strong, supported by good gross profit margins, ROCE, ROE, operating margin and net margin. The company's solvency position appears reasonable, indicating a balanced approach to debt and equity. However, liquidity is a concern, as reflected in lower cash and operating cash flow ratios. Efficiency metrics are weak, particularly in inventory and receivables management. The company's coverage ratios are also somewhat low, suggesting a limited ability to cover interest and dividend payments. Overall, Mono Pharmacare exhibits strong growth and profitability but needs to address its liquidity and efficiency challenges to ensure sustainable financial health.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
N/A
Industry Median
32.52
Small Cap Median
29.21
P/E RATIO
6.06
P/B RATIO
0.60
Industry Median
3.37
Small Cap Median
2.83
P/S RATIO
0.11
Industry Median
3.64
Small Cap Median
2.69
Others
PEG RATIO
0.00
EV/EBITDA RATIO
5.52
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹10.6 as on Jul 13, 2026.
The company exhibits strong growth across multiple dimensions. This robust growth suggests that the company is successfully expanding its market presence and capitalizing on opportunities. The company is well-positioned for continued success and value creation.
| Growth Ratios | Mar 2024 | Mar 2025 |
|---|---|---|
| Revenue Growth Rate | 351.85 | 37.7 |
| Operating Profit Growth Rate | 200 | 33.33 |
| Earnings Per Share (EPS) Growth | 142.11 | 26.81 |
| Asset Growth Rate | 28.57 | 35.8 |
| Net Income Growth Rate | 100 | 50 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Medicamen Organics Ltd | 6.30 | -7.08 | Neutral | -3.75 | -2.50 | -4.02 |
| 2 | Mono Pharmacare Ltd | 6.16 | 6.06 | Neutral | 8.00 | 1.75 | 3.00 |
| 3 | JFL Life Sciences Ltd | 6.07 | 11.29 | Neutral | 12.00 | 1.94 | 6.00 |
| 4 | Walpar Nutritions Ltd | 5.29 | 13.12 | Neutral | 6.66 | 2.09 | 3.00 |
| 5 | Mangalam Drugs and Organics Ltd | 4.50 | -1.00 | Neutral | -15.00 | -27.68 | -44.00 |
| 6 | Lasa Supergenerics Ltd | 4.39 | -2.61 | Highly Undervalued | -7.00 | -6.80 | -34.00 |
| 7 | Sunrest Lifescience Ltd | 4.17 | 7.42 | Highly Undervalued | 10.21 | 3.60 | 8.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Concall Report⬤3rd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Annual Report⬤2nd Jul 26
Annual Report 2025-26
UNDEFINED SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT